• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Kevin Warsh's Financial Disclosure Raises Questions Amid Fed Nomination

chest

Kevin Warsh, nominated by US President Donald Trump to replace Jerome Powell as Federal Reserve Chair, filed a financial disclosure revealing over $100 million in investments in crypto and AI companies, raising concerns about potential conflicts of interest.

user avatarJesper Sørensen

Regulatory Bodies in American Finance Operating with Limited Staff

chest

The SEC and CFTC are currently operating with minimal personnel, which may impact the regulatory landscape for digital assets.

user avatarRajesh Kumar

Analysts Warn of Potential Bear Market Despite Price Rebound

chest

Crypto analysts warn that a bear market bottom has likely not formed, despite recent price rebounds in Bitcoin, Ethereum, and Dogecoin.

user avatarLucas Weissmann

US-Iran War Continues to Impact Cryptocurrency Prices

chest

The ongoing US-Iran war is causing significant volatility in the cryptocurrency market, particularly affecting Bitcoin, Ethereum, and Dogecoin prices.

user avatarFilippo Romano

Sterling Crispin Unveils Prediction Market Bot

chest

Engineer Sterling Crispin has launched a prediction market bot that automatically purchases 'No' on every nonsports market found on Polymarket.

user avatarEmily Carter

Crispin's Bot Implements Targeted Trading Strategy

chest

Sterling Crispin's prediction market bot uses specific filters to enhance its trading strategy, focusing on nonsports markets and purchasing 'No' when the best ask is below 0.65.

user avatarTomas Novak

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.